Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BMS Opens Expanded Devens Biologics Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

BMS Opens Expanded Devens Biologics Facility

$280 million investment adds development and clinical manufacturing capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bristol-Myers Squibb has completed a major expansion at its Devens, MA biologics facility designed to accelerate development of the company’s biologics portfolio  
 
The $280 million investment adds new capabilities with a biologics development building for designing processes for the early production of investigational medicines, and a clinical manufacturing building to produce products to support clinical trials. The Devens site had previously focused solely on large-scale, bulk biologics manufacturing.
 
“Biologics are increasingly important in the treatment of serious diseases and a rapidly growing part of our company’s pipeline of potential new therapies,” said Lou Schmukler, president, Global Manufacturing & Supply. “Bringing together biologics development and clinical and commercial manufacturing on one campus will help accelerate the development of these innovative medicines for patients worldwide.”
 
The expansion initially adds 200 new jobs, and is expected to grow to approximately 350 over time. The two new buildings add approximately 200,000 sq.-ft. to the Devens site, which now comprises eight major buildings in a 600,000 sq.-ft. complex.  
 
“This project represents a significant expansion in the site’s size and mission,” said Greg Guyer, senior vice president, Biologics Development and Operations. “It creates one of the world’s premier integrated biologics facilities, a biologics center of excellence for the company, for the Commonwealth of Massachusetts, and for patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics